Assistant Professor, Department of Pathology
Division of Pulmonary and Critical Care Medicine
Massachusetts General Hospital, Harvard Medical School
In Vivo Optical Coherence Tomography for Early Detection and Diagnosis of Pulmonary Disease
In vivo optical imaging provides microscopic images in patients, in real time, without tissue removal. Due to its high resolution, optical imaging has close parallels with traditional microscopy and can complement and enhance patient care, including in vivo disease detection, biopsy guidance, diagnosis, and resection margin assessment, in a variety of organ systems and disease types. In this talk, I will discuss applications of optical coherence tomography for early detection and diagnosis of pulmonary diseases, particularly lung cancer and interstitial lung disease, and real-time tumor biopsy guidance to increase diagnostic yield.
Lida Hariri, MD, PhD, is an Assistant Professor of Pathology and biomedical optics researcher at Massachusetts General Hospital. She obtained her MD/PhD at the University of Arizona in 2009, with her doctorate in Biomedical Engineering focused on multimodal optical imaging for early cancer detection. She subsequently completed her pathology residency training, and pulmonary and gynecologic pathology fellowships at MGH. Her research interests focus on development, translation and clinical application of high-resolution optical imaging for: 1) early detection and diagnosis of pulmonary diseases, particularly lung cancer and interstitial lung disease, 2) real-time tumor biopsy guidance to increase diagnostic yield, and 3) integrating in vivo optical microscopy into the practice of clinical medicine and pathology. She is a Vice-Chair of the College of American Pathologists (CAP) In Vivo Microscopy Committee.
For more information or to schedule a meeting with the speaker, please contact Hanna Kim.